Skip to main navigation
logo
  • Overview
  • News & Events
    • Press Releases
    • Events and Presentations
  • Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • Financials
    • SEC Filings
    • Annual Reports
    • Quarterly Releases
  • Governance
    • Governance Overview
    • Board of Directors
    • Management
    • Committee Composition
  • IR Resources
    • Email Alerts
    • Contact IR

Press Releases

Press Releases

Recent Releases

September 6, 2022
Athira Pharma Provides Update on Plans for Ongoing LIFT-AD Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients

August 15, 2022
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates

August 3, 2022
Athira Pharma Presents Data from ACT-AD Phase 2 Proof-of-Concept Clinical Study of Fosgonimeton in Mild-to-Moderate Alzheimer’s Patients at the Alzheimer's Association International Conference 2022

Press Releases
May 13, 2021
Athira Pharma Reports First Quarter 2021 Financial Results and Provides Business Highlights
April 21, 2021
Athira Pharma to Participate in Panel Discussion at Sachs 4th Annual Neuroscience Innovation Forum
April 8, 2021
Athira Pharma to Host Educational Webinar on Targeting HGF/MET: A Naturally Occurring Neuronal Repair Pathway
March 25, 2021
Athira Pharma Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Highlights
March 24, 2021
Athira Pharma to Present at Stifel’s 3rd Annual CNS Conference
March 23, 2021
Athira Pharma to Participate in Panel and Corporate Presentations at Life Science Innovation Northwest Conference
March 8, 2021
Athira Pharma Announces Appointment of Barbara Kosacz to its Board of Directors
March 2, 2021
Athira Pharma to Present at H.C. Wainwright & Co. Global Life Sciences Conference
February 10, 2021
Athira Pharma Announces Exercise of Underwriters’ Option to Purchase Additional Shares
January 20, 2021
Athira Pharma Announces Pricing of Public Offering of Common Stock

Pagination

  • First page « first
  • Previous page ‹ previous
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Current page 6
  • Page 7
  • Page 8
  • Page 9
  • Next page next ›
  • Last page last »
Displaying 51 - 60 of 81
< SIGN UP FOR EMAIL ALERTS
CONTACT IR

Athira Pharma, Inc.
18706 North Creek Parkway
Suite 104
Bothell, WA 98011

Main line: (866) 725-0930
Local number: (425) 620-8501
info@athira.com

FCOI Policy

Privacy Policy

© Athira Pharma, Inc. All rights reserved.